Merck &amp; Co.'s new pain reliever, Arcoxia, was gentler on the stomach than an older pain reliever, the drug maker said as it released results of a new study Tuesday.
Drug companies rushing to fill the vacuum left by Merck &amp; Co.'s withdrawal of its best-selling arthritis drug Vioxx are flooding the airwaves with competing advertising claims that are bewildering many patients.
Seven weeks before Merck &amp; Co. pulled the arthritis drug Vioxx off the market because of safety concerns, federal drug regulators downplayed the significance of scientific findings citing the increased risks, documents released Thursday show.
